Main menu

Building capacity for public health bioinformatics in East Africa using a portable sequencing platform


George’s work aims to build capacity in viral outbreak surveillance and real-time portable nanopore sequencing, based on regional priorities.

George’s ‘Nanopore journey’ has developed over 4 or 5 yrs, with current focuses on metagenomic assays, amplicon sequencing of measles and rubella, and SARS-CoV-2.

They sequenced SARS-CoV-2 first in April 2020, shortly after the 1st Kenyan case was identified. ‘Now we have about 120 genomes that we have sequenced’.

Phylogenetic monitoring of SARS-CoV-2 in Kenya: from initial importation via international travel, now to local transmission.

Authors: George Githinji

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag